Inolitazone hydrochloride hydrate (Efatutazone hydrochloride hydrate) is a novel PPARgamma high-affinity agonist, with an EC50 value one-fiftieth that of Rosiglitazone (HY-17386), and shows no inhibitory effect on RIE cells that do not express PPARgamma. Inolitazone hydrochloride hydrate can be used in the research of cancer[1][2].
Molecular Weight:
593.52
CAS Number:
[1048002-36-3]
Formula:
C27H30Cl2N4O5S
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted